ArticlePLoS neglected tropical diseases2025
Tracking progress along the WHO Neglected Tropical Diseases Road Map to 2030: A guide to the Gap Assessment Tool (GAT) and results from the 2023-2024 assessment.
Article in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- From molecular advances to limited clinical impact: The persistent gap in chromoblastomycosis.PLoS neglected tropical diseases · 2026Review
- Estimating the potential impact of global research on neglected tropical diseases on population-level indicators of health access, sanitation, and research capacity.PLoS neglected tropical diseases · 2026Article
- Molecular diagnostics for cutaneous leishmaniasis: progress towards fulfilling the WHO target product profile.Parasitology · 2025Review
- The Role of Big Data in Developing Innovative Predictive Learning Models for Neglected Tropical Diseases within the New Generation of the Evidence-Based Medicine Pyramid.Le infezioni in medicina · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
The monitoring and evaluation (M&E) framework for the World Health Organization (WHO) Neglected Tropical Diseases (NTD) road map includes both quantitative and qualitative assessments of progress at key timepoints up to 2030. These assessments provide critical information to improve programmatic action and identify immediate research needs. Quantitative assessments process multi-sourced data on a predefined number of global indicators. Qualitative assessments are based on results obtained from implementing a Gap Assessment Tool (GAT). Informed by paradigm shifts detailed in the road map, a standardised methodology for the GAT has recently been developed. Methods include online public consultations and focus group discussions. GAT outcomes include a visualisation of progress in a 'heat map', a review of the current status of each NTD, and both disease-specific and cross-thematic recommendations for programmatic and research action. These outcomes provide valuable information not only for country NTD programmes, but also for global stakeholders, so that optimal efforts can be made to achieve established NTD road map goals, and ultimately, to reduce the burden of NTDs in at-risk populations. This manuscript provides a summary of the standardised GAT methodology and results from the implementation of the GAT in 2023-2024. Access is provided to the current status of each NTD with respect to four dimensions that were determined as priority in the 2019-2020 gap assessment (Diagnostics, Monitoring and Evaluation, Access & Logistics, and Advocacy & Funding). Results include a timely consensus on the critical and cross-cutting actions needed to improve respective programmatic impact towards eradication, elimination and control of NTDs globally and nationally.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.